Comparing MR Enterography and Ultrasound for Assessing Crohn's Disease Treatment Response
Official title: Diagnostic Concordance of MR Enterography and Ultrasound for Treatment Response Assessment in Crohn's Disease (MANTRA): a Multicentre, Non-randomised, Multiple-arm, Prospective Cohort Comparison Study
Run by University College, London · NCT06800326 · Data updated 2026-11-12
This study is testing whether MR Enterography or Intestinal Ultrasound is better at showing how well treatment is working for people with Crohn's disease who are 16 and older.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 16 Years to 99 Years |
| Sex | All |
| Enrollment | 155 (estimated) |
| Sponsor | University College, London Academic / other |
| Locations | 1 site (London) |
| Status | Recruiting |
| Started | October 4, 2024 |
| Main results expected | October 1, 2026 |
| Study ends | October 1, 2026 |
| Registry record updated | January 30, 2025 |
| Trial ID | NCT06800326 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 16 and older with small bowel or colonic Crohn's disease who have already undergone baseline imaging.
✕Probably not a fit
Patients who have had surgical resection of affected bowel segments or those unable to provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the diagnostic concordance between MR Enterography (MRE) and Intestinal Ultrasound (IUS) in assessing treatment response in patients with Crohn's disease. It focuses on patients aged 16 and older who have undergone baseline imaging and require follow-up imaging to determine the effectiveness of their treatment. The study seeks to address the variability in imaging modality selection and provide clearer guidance on the use of MRE and IUS for treatment assessment. By comparing these two non-invasive imaging techniques, the study hopes to improve patient management and reduce reliance on more invasive procedures.
Why it matters
Potential benefit: If successful, this study could lead to more accurate and patient-preferred methods for assessing treatment response in Crohn's disease.
How similar studies have gone: While there is limited literature on this specific comparison, previous studies have shown both MRE and IUS to be effective for diagnosing Crohn's disease, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Small bowel or colonic Crohn's disease * 16 years or older * Baseline/pre-treatment MR Enterography or Intestinal Ultrasound already performed as part of standard clinical care * Follow up MR Enterography or Intestinal Ultrasound requested to assess treatment response within 15 months of baseline/ pre-treatment imaging Exclusion Criteria: * Interval resection of diseased segment(s) * Inability to achieve informed consent * Pregnancy * Any contraindication/ intolerance to MRI
Where it's running
-
University College London Hospitals
London, United Kingdom Recruiting
Study contacts
- Principal investigator: Stuart Taylor — University College London Hospitals
- Study coordinator: Maira Hameed
- Email: maira.hameed@ucl.ac.uk
- Phone: 020 7679 9274
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Microencapsulated Propionate vs Butyrate for Crohn's Disease in Remission
This study tests whether microencapsulated sodium propionate can favorably alter the gut microbiota and inflammation in adults with Crohn’s disease, compared with sodium butyrate.
-
Risankizumab for Refractory Perianal Fistulizing Crohn's Disease
This study tests whether risankizumab can help people with Crohn’s disease who have draining perianal fistulas not responding to other treatments.
-
Intestinal ultrasound-guided management for inflammatory bowel disease
This study tests if adding point-of-care intestinal ultrasound at every visit changes treatment decisions for adults with Crohn’s disease or ulcerative colitis undergoing disease assessment.
-
Laser-based sizing of GI lesions during endoscopies
This study tests whether the AccuMeasure laser tool gives more accurate and reliable lesion size measurements during colonoscopies for adults with colon polyps or Crohn’s disease than traditional endoscopic estimates.
-
A Probiotic Approach to Modulating Gut Microbiota in Mild-to-Moderate Ulcerative Colitis
A specific probiotic given rectally will be tested in adults with mild-to-moderate ulcerative colitis to see if it can help manage symptoms.
-
Claudin-2 Immunostaining to Detect Active or Inactive Inflammation in IBD Biopsies
This study tests whether staining for Claudin-2 in intestinal biopsy samples can help identify active vs. inactive inflammation in people with ulcerative colitis or Crohn's disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.